Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 70 Women only

Examining how aging and menopause affect blood vessel responses to low oxygen levels

Official title: Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

Run by University of Missouri-Columbia · NCT06417177 · Data updated 2026-11-12

This study is testing how aging and menopause affect blood vessel responses to low oxygen levels in women by trying different medications to see how they help.

More Aging trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 70 Years
SexWomen only
Enrollment75 (estimated)
SponsorUniversity of Missouri-Columbia
Academic / other
Locations1 site (Columbia, Missouri)
StatusRecruiting
StartedJune 3, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedSeptember 10, 2026
Trial IDNCT06417177 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women assigned at birth who are premenopausal, perimenopausal, or postmenopausal with a healthy weight.

Probably not a fit

Patients who are male, pregnant, or have certain health conditions such as cardiovascular disease or diabetes may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of aging and menopause on how blood vessels respond to hypoxia in women. It focuses on the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women. Participants will receive either a placebo, propranolol, or gemtesa to assess their vascular responses. The study aims to enhance understanding of vascular health in relation to menopause and aging.

Why it matters

Potential benefit: If successful, this study could lead to improved treatments for vascular issues related to aging and menopause.

How similar studies have gone: Other studies have explored vascular responses in aging populations, but this specific focus on menopause and hypoxia is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female assigned at birth
* Pre, peri- or post-menopausal
* Healthy weight (BMI ≥18 and ≤30 kg/m2)

Exclusion Criteria:

* Male (assigned at birth)
* Pregnancy, breastfeeding
* Use of hormone replacement therapies
* Hysterectomy
* Body mass index \>30 kg/m2
* Diagnosed sleep apnea
* Current smoking/Nicotine/Drug use
* Nerve/neurologic disease
* Cardiovascular, hepatic, renal, respiratory disease
* Blood pressure ≥140/90 mmHg
* Diabetes, Polycystic ovarian syndrome
* Communication barriers
* Prescription medications
* Malignant cancer

Where it's running

  • University of Missouri-Columbia
    Columbia, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.